Concepts (63)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Thrombasthenia | 1 | 2020 | 12 | 0.88 | Why? |
| Lupus Coagulation Inhibitor | 3 | 2021 | 262 | 0.40 | Why? |
| Menorrhagia | 1 | 2020 | 11 | 0.22 | Why? |
| Hematologic Agents | 1 | 2020 | 57 | 0.21 | Why? |
| Computed Tomography Angiography | 2 | 2020 | 2153 | 0.20 | Why? |
| Amoxicillin | 1 | 2020 | 98 | 0.20 | Why? |
| Leukemia, Promyelocytic, Acute | 1 | 2020 | 60 | 0.20 | Why? |
| Monitoring, Intraoperative | 1 | 2018 | 140 | 0.17 | Why? |
| Cardiopulmonary Bypass | 1 | 2018 | 158 | 0.17 | Why? |
| Enoxaparin | 2 | 2020 | 1064 | 0.16 | Why? |
| Arterial Occlusive Diseases | 1 | 2020 | 363 | 0.15 | Why? |
| Antiphospholipid Syndrome | 1 | 2021 | 533 | 0.14 | Why? |
| Fibrin Fibrinogen Degradation Products | 2 | 2020 | 5993 | 0.13 | Why? |
| Hemostasis | 1 | 2020 | 811 | 0.13 | Why? |
| Thrombosis | 3 | 2020 | 7504 | 0.13 | Why? |
| Venous Thromboembolism | 2 | 2020 | 4273 | 0.11 | Why? |
| Thorax | 1 | 2020 | 1873 | 0.10 | Why? |
| Endothelium, Vascular | 1 | 2021 | 1751 | 0.10 | Why? |
| Anticoagulants | 3 | 2020 | 9563 | 0.10 | Why? |
| Heparin | 2 | 2020 | 2600 | 0.09 | Why? |
| Hemorrhage | 1 | 2020 | 3013 | 0.09 | Why? |
| Feces | 1 | 2020 | 4235 | 0.08 | Why? |
| C-Reactive Protein | 1 | 2020 | 7972 | 0.07 | Why? |
| Pulmonary Embolism | 1 | 2020 | 4775 | 0.05 | Why? |
| Antibodies, Anticardiolipin | 1 | 2021 | 208 | 0.05 | Why? |
| Models, Theoretical | 1 | 2018 | 6659 | 0.05 | Why? |
| Whole Blood Coagulation Time | 1 | 2018 | 10 | 0.05 | Why? |
| Femoral Artery | 1 | 2020 | 213 | 0.04 | Why? |
| Anti-Bacterial Agents | 1 | 2020 | 10083 | 0.04 | Why? |
| Obesity | 1 | 2018 | 7388 | 0.04 | Why? |
| Treatment Outcome | 2 | 2020 | 51732 | 0.04 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.04 | Why? |
| Antibodies, Antiphospholipid | 1 | 2021 | 519 | 0.04 | Why? |
| Syndrome | 1 | 2020 | 1310 | 0.04 | Why? |
| Lower Extremity | 1 | 2020 | 593 | 0.04 | Why? |
| France | 2 | 2020 | 12074 | 0.03 | Why? |
| Hospitalization | 2 | 2020 | 54280 | 0.03 | Why? |
| Ischemia | 1 | 2020 | 901 | 0.03 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.03 | Why? |
| Propensity Score | 1 | 2020 | 2690 | 0.03 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.03 | Why? |
| Lung | 1 | 2020 | 31049 | 0.03 | Why? |
| Female | 6 | 2020 | 380317 | 0.03 | Why? |
| Fatal Outcome | 1 | 2020 | 3438 | 0.03 | Why? |
| Adolescent | 1 | 2020 | 86841 | 0.02 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.02 | Why? |
| Lung Transplantation | 1 | 2020 | 1554 | 0.02 | Why? |
| Humans | 9 | 2021 | 930598 | 0.02 | Why? |
| Middle Aged | 5 | 2020 | 270681 | 0.02 | Why? |
| Prospective Studies | 2 | 2020 | 43301 | 0.02 | Why? |
| Transplant Recipients | 1 | 2020 | 4982 | 0.02 | Why? |
| Intensive Care Units | 2 | 2020 | 29594 | 0.02 | Why? |
| Aged | 4 | 2020 | 215776 | 0.02 | Why? |
| Follow-Up Studies | 1 | 2021 | 17020 | 0.01 | Why? |
| Male | 5 | 2020 | 367725 | 0.01 | Why? |
| Disease Progression | 1 | 2020 | 13580 | 0.01 | Why? |
| Pandemics | 4 | 2020 | 389249 | 0.01 | Why? |
| Critical Illness | 1 | 2020 | 17281 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2020 | 25144 | 0.01 | Why? |
| Adult | 2 | 2020 | 244371 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.01 | Why? |
| Retrospective Studies | 1 | 2020 | 105322 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2018 | 88759 | 0.01 | Why? |